Luca Idolazzi (L Idolazzi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Systemic Sclerosis

Tyrosine Kinase

Patient Reported

Body Mass Index

Top Venues

Clinical rheumatology

Therapeutic advances in musculoskeletal disease

The British journal of dermatology

Azienda Ospedaliera Universitaria Integrata Verona

Università degli Studi di Verona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliera Universitaria Integrata Verona Mar 01 2013

Italy

Assistant :: Department of Medicine

Education History

Università degli Studi di Verona Jan 01 2012 - Jan 01 2015

Italy

PHD :: Scuola di Dottorato in Scienze della Vita e della Salute

Publications

Riccardo Bixio, Giovanni Adami, Eugenia Bertoldo, Alessandro Giollo, Andrea Morciano, Davide Bertelle, Giovanni Orsolini, Luca Idolazzi, Maurizio Rossini, Ombretta Viapiana
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis. Therapeutic advances in musculoskeletal disease 14 (2022)
Paolo Gisondi, D Geat, Luca Idolazzi, G Girolomoni
Relapse of psoriatic arthritis in patients with active psoriasis switched from tumour necrosis factor-α to interleukin-17A inhibitor. The British journal of dermatology 181 (3) (2019)
A Fassio, I Giovannini, Luca Idolazzi, A Zabotti, A Iagnocco, G Sakellariou
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review. Clinical rheumatology 39 (5) (2019)
Luca Idolazzi, Alen Zabotti, Angelo Fassio, Enzo Errichetti, Camilla Benini, Elisabetta Vantaggiato, Maurizio Rossini, Salvatore De Vita, Ombretta Viapiana
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions. Clinical rheumatology 38 (3) (2019)